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Abstract 19 
 20 
Major challenges in the development of novel implant surfaces for artificial joints 21 
include osteoblast heterogeneity and the lack of a simple and sensitive in vitro 22 
assay to measure early osteogenic responses.  Raman spectroscopy is a label-23 
free, non-invasive and non-destructive vibrational fingerprinting optical 24 
technique that is increasingly being applied to detect biochemical changes in 25 
cells. In this study Raman spectroscopy has been used to obtain bone cell-26 
specific spectral signatures and to identify any changes therein during 27 
osteoblast commitment and differentiation of primary cells in culture.  Murine 28 
calvarial osteoblasts (COBs) were extracted and cultured and studied by 29 
Raman spectroscopy over a 14 day culture period.  Distinct osteogenic Raman 30 
spectra were identified after 3 days of culture with strong bands detected for 31 
mineral: phosphate 𝜐3 (1030 cm-1) and B-type carbonate (1072 cm-1), DNA (782 32 
cm-1) and collagen matrix (CH2 deformation at 1450 cm-1) and weaker 33 
phosphate bands (948 and 970 cm-1). Early changes were detected by Raman 34 
spectroscopy compared to a standard enzymatic alkaline phosphatase (ALP) 35 
assay and gene expression analyses over this period. Proliferation of COBs 36 
was confirmed by fluorescence intensity measurements using the Picogreen 37 
dsDNA reagent. Changes in ALP levels were evident only after 14 days of 38 
culture and mRNA expression levels for ALP, Col1a1 and Sclerostin remained 39 
constant during the culture period. Sirius red staining for collagen deposition 40 
also revealed little change until day 14. In contrast  Raman spectroscopy 41 
revealed the presence of amorphous calcium phosphate (945-952 cm-1) and 42 
carbonated apatite (957-962 cm-1) after only 3 days in culture and octacalcium 43 
phosphate (970 cm-1) considered a transient mineral phase, was detected after 44 
5 days of COBs culture. PCA analysis confirmed clear separation between 45 
time-points.  This study highlights the potential of Raman spectroscopy to be 46 
utilised for the early and specific detection of proliferation and differentiation 47 
changes in primary cultures of bone cells. 48 
 49 
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1. Introduction 50 
Studies of bone forming osteoblast cells have significant medical impact with 51 
stimulation of osteoblast formation and activation continuing to have wide 52 
clinical demand. Although bone exhibits some highly conserved factors in its 53 
development, remodelling and repair, it is also apparent that the response to 54 
many in vivo challenges is not always consistent in different regions of bone [1-55 
3]. These observations suggest that osteoblast populations are inherently 56 
heterogeneous and support a current hypothesis that their identity is specific to 57 
their local environment [4]. In recent attempts to clinically improve the success 58 
of joint replacement much focus has been on the study of the bone cell-implant 59 
interface with the long term success of joint replacement relying on sufficient 60 
osteoblast adherence, proliferation and differentiation in promoting 61 
osseointegration in specific regions. [5-7]. Historically, successful 62 
osseointegration has been assessed post implantation radiographically. 63 
However the study of osteoblast activity in vitro on implant surfaces could 64 
improve the development of implant coatings and allow for more accurate 65 
predictions of posteoperative osseointegration success. While in this paper we 66 
study osteoblast activity on quartz cover slips it is relevant and will provide 67 
insight for implant surfaces, subsequent studies and their modelling. 68 
 69 
Osteoblast cells derive from mesenchymal progenitors and transition to pre-70 
osteoblasts before finally becoming bone forming osteoblasts [8]. The 71 
differentiation process of osteoblasts is often defined by the presence of these 72 
three different-stage cell types but their identities are not yet clearly defined. 73 
Early transgenic studies describe the genes required for osteoblast 74 
differentiation [9, 10].  It is now generally accepted that transcription factors 75 
Runx2, osterix and β-catenin are involved in the regulation of osteoblast 76 
differentiation [11]. Currently, identifying mesenchymal progenitor commitment 77 
to the osteoblast lineage is in the expression of Runx2 and osterix, at which 78 
point they are considered pre-osteoblasts [12, 13].  Mature osteoblasts are 79 
characterised by their ability to secrete large amounts of extracellular proteins 80 
including osteocalcin alkaline phosphatase (ALP) and type I collagen, the main 81 
constituents of osteoid matrix which forms prior to osteoblast commitment and 82 
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mineralisation [8, 14]. The final stage of bone formation is mineralisation which 83 
is thought to initiate with the formation of hydroxyapatite (HA) crystals inside 84 
matrix vesicles (MVs) which are 50-200 nm in diameter and bud from the 85 
surface membrane of hypertrophic chondrocytes and osteoblasts [15-18].  86 
Inorganic calcium (Ca2+) and phosphate (Pi) ions accumulate inside MVs 87 
instigating the breakdown of the MV membrane, releasing HA crystals into the 88 
extracellular fluid where they propagate on the collagenous extracellular matrix 89 
[16, 19-21]. Inorganic phosphate ions also play a key role in regulating 90 
mineralisation.  91 
 92 
During in vitro bone formation, expression of mature osteoblast specific genes 93 
and subsequent mineralisation typically takes place between 14 to 28 days [22, 94 
23]. An ability to detect and quantify osteoblast differentiation early during the 95 
culture process is attractive in the comparative study of distinct osteoblast 96 
populations and also clinically for evaluating growth on implant surfaces. 97 
Raman spectroscopy, an optical vibrational finger-printing technique, is label-98 
free, non-invasive and non-destructive and can be a more sensitive means 99 
compared to conventional biochemical methods to detect osteogenesis.  100 
 101 
Raman spectroscopy has gained a lot of interest in recent years as a potential 102 
diagnostic tool for detecting such early biochemical changes in cells [24]. 103 
Raman spectroscopy has also indeed been widely applied to characterise bone 104 
and its constituents [25-27]. Its capability to detect bone nodule formation in in 105 
vitro secondary cell cultures has also been demonstrated although under high 106 
mineralisation conditions [28, 29]. Recently the application of Raman 107 
spectroscopy to grade live osteosarcoma cells was also investigated by Chiang 108 
et al, who measured levels of hydroxyapatite produced by osteosarcoma cell 109 
lines, a possible measure of malignancy [30].  By characterising the Raman 110 
signatures of different cell types, researchers have been able to apply this 111 
technique to monitor the differentiation of stem cells with Raman effectively 112 
monitoring the osteogenic differentiation of human mesenchymal stem cells 113 
(hMSCS) from 7 days of in vitro culture [31]. Hung et al also used hMSCs to 114 
investigate matrix formation as a measure of maturation of live hMSCs [32]. 115 
Although this paper has demonstrated the feasibility of using Raman 116 
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spectroscopy to quantitatively analyse hMSC maturity, here we perform a 117 
thorough investigation on primary osteoblast cells isolated directly from murine 118 
neonatal bone tissue, and have been able to detect and characterise spectral 119 
changes over 14 days of culture due to proliferation, differentiation and 120 
deposition of matrix in osteoblasts. Whilst Hung et al were unable to detect early 121 
amorphous forms of calcium phosphate, we were able to not only detect 122 
different transient mineral species, but also quantify changes over time. 123 
Moreover, we study osteoblast cultures in natural growth (physiological) rather 124 
than over-mineralising conditions most often used by Raman researchers 125 
studying similar bone cells or osteogenesis [29]. Furthermore, we show that 126 
these changes are observed by Raman spectroscopy earlier than typical 127 
enzymatic and gene expression assays. Our study therefore establishes 128 
Raman spectroscopy as a simple, label-free, non-invasive and non-destructive 129 
alternative tool for assessing primary bone cultures and early changes therein 130 
with many applications in the field of skeletal regeneration. 131 
 132 
2. Materials and Methods 133 
 134 
2.1 Reagents 135 
 136 
All tissue culture reagents, including α Minimum essential medium (αMEM) (no. 137 
22571) and fetal calf serum (FCS) (no. 102701) were purchased from Invitrogen 138 
Life Technologies (Paisley, UK). All other reagents were purchased from Sigma 139 
unless otherwise stated. 140 
 141 
2.2 Isolation and culture of calvarial osteoblasts. 142 
 143 
Primary mouse calvarial osteoblasts (COBs) were obtained by sequential 144 
enzyme digestion of excised calvarial bone from 4-day-old neonatal mice 145 
(c57/bl6) using a 4-step process (CCEC; [50]). The first digest (1 mg/ml 146 
collagenase type Ⅱ in HBSS for 10 min) was discarded. The following 3 digests 147 
(fraction 1, 1 mg/ml collagenase type Ⅱ in HBSS for 30 min; fraction 2, 4 mM 148 
EDTA in PBS for 10 min; fraction 3, 1 mg/ml collagenase type Ⅱ in HBSS for 149 
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30 min) were retained. During the final digestion, the cells obtained from 150 
fractions 1 and 2 were resuspended in αMEM supplemented with 10% heat-151 
inactivated FCS (HI FCS), 5% gentamicin, 100 U/ml penicillin, 100 μg/ml 152 
streptomycin. The cells from fraction 3 were then combined with fractions 1 and 153 
2 for expansion. The cells were cultured in 75 cm2 flasks (6 calvaria/ flask) for 154 
7 days in a humidified atmosphere of 5% CO2-95% air at 37˚C until confluent. 155 
 156 
Upon confluence COBs were either plated into 12 well tissue culture plates or 157 
quartz coverslips (UQG optics CFQ-1017 #No1.5, thickness: 0.17 mm, Ø 10)  158 
at density of 7900 cells/cm2. Cells were cultured for 3, 5, 7 and 14 days in αMEM 159 
supplemented with osteogenic media containing 50µg/ml ascorbic acid (AA) 160 
and 2.5 mM β- Glycerophosphate (BGP). For Raman spectroscopy COBs were 161 
fixed with 4% w/v paraformaldehyde and stored in PBS prior to imaging.  162 
 163 
2.3 Alkaline Phosphatase activity elution assay and staining 164 
 165 
COBs for elution assay were grown in 12 well plates as described above, 166 
washed twice with PBS before treating with 100% ethanol for 1 minute. Fixative 167 
was removed and cells were washed twice in distilled water. P-nitrophenol 168 
substrate (1mg/ml) was then added to a working solution of 70% dH20, 20% 169 
0.1M NaHCO3 and 10% 30mM MgCl2, pH was adjusted to 9.5. 500 µl of 170 
working solution was added to each well and incubated for 30 minutes at 37°C. 171 
2x200 µl of eluted solution was removed and pipetted into a 96 well plate. 172 
Absorbance was measured after 1 minute at 405 nm. Concentration of 173 
nmols/ml/minute was calculated using a standard curve of known 174 
concentrations of p-nitrophenol solution (0.05, 0.1, 0.15, 0.2, 0.25mM). 175 
 176 
ALP activity was also visualised by histochemical staining at day 3, and 14. 177 
After fixation with methanol: acetone cells were rinsed then treated with 178 
naphthol AS-MX as a substrate and Fast blue to produce a coloured precipitate. 179 
 180 
2.4 Sirius Red collagen staining 181 
 182 
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To visualise collagen deposition over time, Sirius red staining was performed 183 
at days 3, 5, 7 and 14. COBs were grown in 12 well plates at a density of 5 x 184 
104 cells/well, with and without BGP and AA. After the desired culture period, 185 
cells were washed twice with PBS before fixing with 70% ethanol for 1 hour. 186 
After fixation, cells were dried at 37°C and stained with Sircol Dye Reagent 187 
(Biocolor, County Antrim, UK) for 1 hour. After staining, cells were washed with 188 
dH20 and allowed to air dry.  189 
 190 
2.5 RNA Extraction and cDNA synthesis 191 
After removal of culture media and washing with PBS, COBs were disrupted 192 
with lysis buffer. Lysates were stored at -80°C before RNA extraction. Total 193 
RNA was isolated using Qiagen RNeasy Mini Kit according to the 194 
manufacturer's instructions. The RNA for each sample was determined using a 195 
Nanodrop UV-vis spectrophotometer. cDNA was synthesised using the RT2 196 
First Strand Kit (Qiagen catalogue #330401). Osteogenesis array carried out 197 
using PAMM-026ZA-6 - RT² Profiler™ Mouse Osteogenesis PCR Array 198 
(Qiagen catalogue #33023). Used Bio-Rad/MJ Research Chromo4 thermal 199 
cycler. Thermal cycling conditions included a 10 minute HotStart DNA Taq 200 
activation step at 95°C, followed by 40 cycles of 95°C for 15 seconds and 55°C 201 
for 30 seconds. A melting curve was included with temperature increase from 202 
65°C to 95°C with 0.2°C increments for 1 second. 203 
 204 
2.6 Genomic DNA isolation and Picogreen assay  205 
 206 
COBs for genomic DNA extraction were cultured in 6 well plates as described 207 
above. After desired culture period, medium was removed and cells were 208 
washed with PBS, before the addition of 250 µl Trypsin/EDTA.  An equal 209 
volume of α- MEM medium was added to the cells after dissociation to 210 
neutralise the trypsin. COBs were transferred to an Eppendorf and centrifuged 211 
at 10,000 RPM for 5 minutes. Pelleted cells were resuspended in 200 µl PBS 212 
and PureLink™Genomic DNA MiniKit was used to isolate genomic DNA 213 
according to manufacturer’s instructions.  214 
Once genomic DNA was obtained, the Quant-iT™PicoGreen®dsDNA reagent, 215 
a fluoresecent nucleic acid stain was used to quantitate double stranded DNA 216 
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present in the genomic DNA isolated from COBs.  The fluorescence assay was 217 
measured with a Hitachi F2500 fluorescence spectrophotometer. Samples 218 
were excited at 480 nm and fluorescence intensity was measured at 520 nm.  219 
DNA concentration was determined from a previously generated standard 220 
curve of known DNA concentrations (1 µg/ml, 100 ng/ml, 10 ng/ml, 1 ng/ml and 221 
a blank of TE buffer only). 222 
 223 
2. 7 Raman Spectroscopy 224 
 225 
For Raman spectroscopy calvarial osteoblasts (COBs) were cultured for 3, 5, 7 226 
and 14 days in osteogenic media (as previously described) on sterilised quartz 227 
coverslips. Cells were washed with Dulbecco’s phosphate buffered saline (PBS) 228 
before fixing with 4% paraformaldehyde for 5 minutes at room temperature. 229 
After fixation COBs were washed in PBS. Raman spectra were obtained using 230 
a Renishaw® inVia Raman microscope with a 532 nm laser and a Leica 63x 231 
(NA: 1:2) water immersion objective in combination with WIRE 3.4 software. 232 
The diffraction limited spot size is ~300 nm. However, we note that the spectral 233 
collection was not confocal. Therefore the signal was collected from a focal 234 
volume defined by the spot size. For consistency Raman spectra were always 235 
collected from single cells over the nucleus. The nucleus was selected as a 236 
marker area as it was the most distinctly visible feature of cell in the brightfield 237 
image. Spectra were acquired from 20 cells and for each spectrum 2 238 
accumulations of 30 s exposure were collected.   239 
Cosmic ray artefacts were removed using WiRE 3.4. Before plotting the spectra 240 
they were processed using IRootLab, a MATLAB based toolbox for vibrational 241 
spectroscopy. Prior to general processing, background contribution from quartz 242 
was removed. Wavelet denoising and baseline correction was carried out by 243 
fitting a 6th order polynomial in IRootlab [33, 34]. 244 
 245 
2.8 Analysis 246 
 247 
Curve fit of Raman peaks carried out using WIRE 3.4 software. Peak heights 248 
were measured of class means of the different time points by curve fitting. For 249 
evaluating contributions to different biomolecules the fittings were restricted to 250 
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the spectral regions of 760-870 cm-1 for DNA, 900-980 cm-1 for the 251 
ν1PO
3
4
¯phosphate region and 1400- 1490 cm-1 for the CH2 deformation 252 
(extracellular matrix component of collagen). A number of mixed Gaussian-253 
Lorentzian curves were fitted tor each region. Where possible the curve fitting 254 
was initiated by using the same number of peaks although these shifted with 255 
the time-course. For example at day 3, 9 peaks were selected to deconvolve 256 
the phosphate region, but at day 7 and 14 only 7 were needed. These changes 257 
reflect the changes in phosphate disorder [35]. 258 
 259 
3. Results and Discussion 260 
3.1 Assessment of primary calvarial osteoblasts differentiation by 261 
Raman spectroscopy 262 
 263 
To assess the differentiation of primary calvarial osteoblasts (COBs) by Raman 264 
spectroscopy, osteoblasts were isolated from the calvaria of 4 day old neonate 265 
mice by sequential collagenase/EDTA digestion (Figure 1A). Cells were 266 
cultured for up to 14 days in standard tissue culture conditions, before fixation 267 
with 4% PFA.  A single spectrum was collected targeting each cell nucleus. 20 268 
spectra were acquired for a cell culture sample. Overall the COBs’ Raman 269 
spectra are composed of characteristic biomolecular peaks, first assigned by 270 
Puppels, now accepted as biomarkers for cells [36]. Spectra were collected 271 
within the “Raman fingerprint region” between 600 cm-1 – 1750 cm-1. Strong 272 
Raman bands were detected for DNA (782 cm-1) and phenylalanine (1004 cm-273 
1). The quartz cover slip could have contributed to the background (Figure S1) 274 
but the strong Raman signal at 782 cm-1 is attributable to the cells. The 275 
presence of such a large peak in this region has been previously detected in a 276 
number of studies [37-39]  A range of protein bands associated with collagen 277 
and the extracellular matrix were observed including  CH2 deformation at 1450 278 
cm-1, Amide III and Amide I [40]. Mineral bands linked with osteoblasts and bone 279 
tissue were also detected namely Phosphate ν3 (1030 cm-1) and B-type 280 
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carbonate (1072 cm-1) as well as weak phosphate bands between 948 and 970 281 
cm-1.  282 
 283 
Peak assignment and spectral analysis was carried out on class mean spectra 284 
shown in Figure 1C. The class means retain the previously mentioned spectral 285 
peaks, highlighted in Figure 1C, and they also display components ascribed to 286 
mineralised tissue including Amide I, Amide III, CH2 deformation for matrix, and 287 
Phosphate 𝜈3 (1030 cm-1) and B-type carbonate (1072 cm-1) bands for mineral  288 
[41, 42].  Broad peaks in the phosphate region (948 - 970 cm-1) are also 289 
detectable. Before looking at the differences in biochemical composition 290 
Figure 1. Raman spectroscopy of calvarial osteoblasts (COBs). (A) Schematic of the experimental methodology 
for this work is shown. Murine calvarial osteoblasts were extracted from 4 day old neonates by sequential 
collagenase digestion. Cells were cultured up to 14 days on quartz coverslips in standard tissue culture 
conditions. Following fixation, cell nuclei were scanned with 532 nm laser and spectra obtained from 20 cells 
per time point. (B) Phase contrast images of COBs in culture highlight phenotypic changes following 14 days of 
culture in osteogenic media. Scale bar equivalent to 250 µm. (C) Class means of Raman spectra at day 3 (a), 5 
(b), 7 (c) and 14 (d). The spectra show differences in key spectral regions over time. 
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provided by Raman spectroscopy, we present the results of biological 291 
techniques traditionally used to evaluate osteoblast function. 292 
 293 
3.2 Enzymatic ,mRNA, collagen and DNA measurements of calvarial 294 
osteoblasts.  295 
 296 
For assessment of osteoblast maturity and validation of differentiation status, 297 
conventional assays and molecular techniques were employed. The Alkaline 298 
phosphatase (ALP) activity assay has become the standard assay to measure 299 
osteoblast activity in vitro. In vivo, mature osteoblasts secrete ALP, for which 300 
PPi serves as a substrate and when hydrolysed by ALP produces Pi, which 301 
accumulates in MVs along with Ca2+ during the early phase of mineralisation 302 
[21].   In vitro, confluent osteogenic cultures are thought to enter an initiation 303 
phase after 7 to 14 days, during which time cells will proliferate, express ALP 304 
and secrete collagen matrix [43]. The secretion of ALP in osteogenic cultures 305 
increases until the cells reach maturation phase and the onset of mineralisation 306 
after about 14 – 21 days [23, 43]. Quantitative analysis shows an increase in 307 
ALP over time in osteogenic cultures, with the most apparent increase between 308 
day 7 and 14 (Fig. 2A).This observation is confirmed by visualisation of ALP 309 
activity (Figure 2A; upper panel). Osteoblasts cultured only in basal medium, 310 
without the addition of osteogenic mediators (BGP and AA), show little evidence 311 
of ALP activity until day 14 of culture. These results highlight that early changes 312 
(day 3 to day 7) are not detectable by ALP assay and therefore call for a more 313 
sensitive approach. 314 
 315 
 316 
 317 
 318 
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 319 
Sirius Red staining for deposited collagen 320 
Figure 2. Alkaline Phosphatase (ALP) activity and Sirius red staining of cultured calvarial osteoblasts (COBs).  
(A) Results for ALP activity are shown. Cells were cultured in osteogenic (+) or basal medium (-), fixed with 100% 
ethanol and reacted for ALP and eluted. Data are represented as mean concentration of 2 replicates ± STD. The 
inset shows exemplar images of cells at Day 3 and Day 14 stained for ALP activity. (B) Images for Sirius red 
staining of COBs for collagen deposition at indicated time points +/- osteogenic media. Scale bar represents 250 
µm. 
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To assess the deposition of collagen in the COBs cultures over time, cells 321 
cultured with and without osteogenic mediators for 3, 5, 7 and 14 days were 322 
stained with Sircol Sirius red dye reagent.  After staining cells were visualised 323 
using phase contrast microscopy (Figure 2B). No obvious differences were 324 
detected over time in the cells cultured in non- osteogenic media (Figure 2B, ‘-325 
‘ row). COBs that were cultured in osteogenic media (Figure 2B ‘+’ row) reveal 326 
a fluctuating increase in collagen deposition over time. Nevertheless, at 14 days 327 
the COBs cultured in osteogenic media show the most intense and widespread 328 
staining, but little difference is discernible between day 3 and day 5 of 329 
osteogenic culture.   330 
 331 
mRNA analysis  332 
To confirm COBs were differentiating as expected, RT² Profiler PCR Array 333 
Gene Expression Analysis was carried out. From this array a number of genes 334 
were selected to investigate osteogenic commitment by COBs; Col1a1 335 
(encodes the major component of collagen type I), SOST (sclerostin, involved 336 
in regulation of bone formation in osteoblasts) and ALP (alkaline phosphatase). 337 
Interestingly all of these genes show unchanged expression levels between day 338 
5 and day 14 (Figure 3A). This data highlights the lack of sensitivity to effectively 339 
detect changes in early in vitro osteogenesis. It is not unusual to observe 340 
increases in enzymatic activity as seen in the ALP assay between day 7 and 341 
day 14 (Figure 2A), that are not mirrored in the mRNA expression. This 342 
phenomenon of ALP activity not matching mRNA has been previously reported 343 
by Weiss et al in a study of the sub-epithelial stroma whereby during gestation 344 
ALP activity peaked at day 7, but this elevation in enzyme activity was not 345 
preceded by induction of mRNA [44]. Although gene expression analysis can 346 
provide some insight into early osteogenic behaviour, it is clear that early 347 
detection is not always possible and a more sensitive assay is needed to garner 348 
an enhanced understanding of osteogenesis.  349 
 350 
 351 
 352 
 353 
DNA quantitation 354 
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Early osteogenic commitment is typified by modifications in cellular proliferation. 355 
To investigate whether these changes were apparent in our COBs cultures, 356 
dsDNA concentration was measured using the Quant-iT™Picogreen® reagent. 357 
dsDNA present in genomic DNA isolated from COBs cultured for either 3, 5, 7 358 
or 14 days was quantified by the addition of the Picogreen dye. Samples were 359 
excited at 480 nm and fluorescence intensity was measured at 520 nm. Figure 360 
3B shows the concentration of dsDNA present in each time point, determined 361 
from a previously generated standard curve of known DNA concentrations. 362 
There is an increase in DNA concentration between day 3 and 5 of COBs 363 
culture, indicating a proliferation phase. The DNA concentration continues to 364 
Figure 3. Osteogenic gene expression and fluorescence quantitation of DNA of calvarial osteoblasts cultured for 
up to 14 days. (A) mRNA expression levels of Col1a1, Sclerostin (SOST) and ALP at different time points. They were 
normalised to HsP. At each desired time point cells were lysed and RNA was isolated from osteoblasts. After 
generation of cDNA an RT² Profiler PCR Array was performed comprising one sample per well/gene.  (B) Quant-
iT™Picogreen® fluorescence intensities of dsDNA isolated from COBs. Samples were excited at 480 nm and 
fluorescence intensity was measured at 520 nm.  dsDNA concentration was determined from previously generated 
standard curve of known DNA concentrations.  
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increase at day 7. At day 14, however, there is a drop in DNA concentration, 365 
suggesting the cells have switched to a proliferative state. 366 
 367 
3.3 Raman spectral changes during early osteogenesis identified by 368 
univariate deconvolution analysis   369 
 370 
To assess whether Raman spectroscopy can indeed allow us to detect early 371 
biochemical changes in cells, without losing the heterogeneity of the cell 372 
population, in this section, we analyse spectral changes evident from the class 373 
means (Figure 1C) in more detail. 374 
Univariate analysis of class means, revealed a very strong Raman peak at 782 375 
cm-1 after 3 days of osteogenic COBs culture After 5 days of osteogenic culture, 376 
peak intensity decreases, suggesting a drop in DNA concentration. This peak 377 
increases between day 7 and day 14. The peak intensities extracted after 378 
deconvolution confirms this apparent change in DNA concentration (Figure 4A). 379 
In non- osteogenic COBs cultures, deconvolution of peak height intensities 380 
revealed that after the initial decrease between day 3 and day 5, very little 381 
change is detected between day 5 and day 7, but a considerable increase is 382 
shown between day 7 and 14 for the nucleic acid peak at 782 cm-1 (Figure S2D).  383 
Previous studies have indicated that DNA concentration in cells is related to 384 
proliferative status [45, 46].  Our data suggests that COBs are proliferating at 385 
first until confluence is reached (at day 5) at which point DNA concentration 386 
drops as the cells begin to differentiate. This is in keeping with current 387 
understanding of osteoblast behaviour in culture. After isolation, primary 388 
osteoblasts will first form collagen matrix and then proliferate on a surface; once 389 
confluence is reached, after around 7 days in culture, the fibroblast like pre-390 
osteoblasts start to differentiate into a more mature form of osteoblast [47]. The 391 
Picogreen assay showed an increase in DNA concentration until day 7, which 392 
coincides with the switch from proliferation to differentiation at day 14 and a 393 
decrease in DNA concentration. Osteoblasts reach maturity after 14 days in 394 
culture [43].  Analysis of the Raman peaks indicates that after an initial drop in 395 
DNA at day 3, there is a gradual increase in proliferation up to day 14. This 396 
increase in DNA at day 14 coincides with an increase in extracellular matrix 397 
(ECM) associated Raman frequencies (Fig 4B) as well as ALP activity (Fig 2AB 398 
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and an overall increase in phosphate species present (supplementary 399 
information Fig. S1).  This behaviour suggests the COBs are differentiating and 400 
preparing to start mineralising. Mature osteoblasts start to mineralise between 401 
21 and 28 days and before that the extracellular matrix (ECM) comprising of 402 
mainly collagen is laid down. By targeting the nuclei of individual cells, Raman 403 
spectra retain the heterogeneous nature of primary osteoblasts in culture. To 404 
isolate DNA from cells, it is necessary to lyse a large number of cells, thereby 405 
losing the individual heterogeneity and any subtle variation that might be 406 
present in population level concentrations. 407 
After 3 days of either osteogenic or non- osteogenic culture, ECM components 408 
were detected using Raman spectroscopy. These have been previously 409 
described and include bands at 852 cm-1 (C-C proline, hydroxyproline), 1003 410 
cm-1 (phenyalanine ring breathing), 1255 cm-1 (Amide III), 1450 cm-1 (CH2 wag) 411 
and 1660 cm-1 (Amide I) [41, 48, 49].  412 
The CH2 wag, considered to be a component of collagen, was chosen for further 413 
analysis of general matrix production [50-54]. Deconvolution analysis of peak 414 
height was carried out on spectra from COBs cultured in osteogenic media. 415 
There was no significant change in peak position or intensity in this component 416 
of the collagen matrix over the early time points (Figure 4B). There is a 417 
significant increase at day 14, which corresponds with increases in phosphate, 418 
DNA and ALP activity. This compares well with the results from Sirius Red 419 
staining where very little difference was detected in non-osteogenic COBs 420 
Figure 4. Raman spectral data analysis over time for COBs. Peak intensities for (A) Nnucleic acids (782 cm-1) show 
gradual increase after day 5 of culture and (B) Collagen (CH2 wag 1450 cm-1) showing little change in peak height 
until day 14 of culture. Spectral deconvolution was carried out on averaged pre-processed spectra of COBs 
cultured each of the time points. Data is presented as the mean of deconvoluted peak intensity ± SEM (p< 0.05 
*** p<0.0001 ****) 
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cultures using the Sirius red collagen stain where an increased collagen 421 
staining was observed in the osteogenic cultures at day 14, but little difference 422 
visible in the early time points. This is similar to that observed with Raman 423 
spectroscopy (Figure 4B). The results with the controls (non-osteogenic 424 
cultures) are also largely similar in that there is a small increase at Day 14 and 425 
at other days over the time course there are little changes. Deconvolution of 426 
spectra taken of COBs grown in non- osteogenic medium also shows little 427 
change in the CH2 wag matrix component before day 14 (Figure S2C). Until 428 
day 14 the ECM is dominated by a stable collagen component, the presence of 429 
the phosphate intermediates indicates that mineralisation has not yet taken 430 
place and the matrix is immature.  431 
  432 
3.4 Raman spectroscopic analysis of phosphates in COBs 433 
 434 
Osteoblasts ultimately form fully mineralised and mature bone which is primarily 435 
calcium hydroxyphosphate (hydroxyapatite or HA). However, before the stable 436 
form of hydroxyapatite is reached, a range of calcium phosphate intermediates 437 
can be formed. Amorphous calcium phosphate (ACP) is thought to be the first 438 
insoluble phase of calcium phosphate [55]  This further goes through several 439 
intermediate forms and transient mineral species, including carbonated apatite 440 
(CAP) and octacalcium phosphate (OCP) before formation of hydroxyapatite 441 
(Figure 5).    The presence of transient mineral species has previously been 442 
investigated in calvarial cultures and in the formation of bone in vivo [42, 48, 443 
49].  444 
 445 
 446 
 447 
In this study, particular attention was paid to the presence of intermediate 448 
calcium phosphate species; amorphous calcium phosphate (ACP 945-952 cm-449 
1) [42, 49], carbonated apatite (CAP 957-962 cm-1) [41, 49] and octacalcium 450 
phosphate (OCP 970 cm-1) [53, 56] (Table 1).  451 
 452 
Figure 5. Reaction scheme representing the conversion of amorphous calcium phosphate (ACP) to crystalline 
hydroxyapatite (HA). Carbonated apatite (CAP) and octacalcium phosphate (OCP) are postulated as intermediate 
phosphates. The bi- directional arrows illustrate the transient nature of these phosphate intermediates. 
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Table 1. Band assignments for Raman spectra of mineral components.  453 
 454 
 455 
To track the transformation of phosphates from amorphous broad peaks to 456 
phosphates with more crystalline properties, deconvolution of peaks was 457 
carried out in the the ᶹ
1 
PO
3
4
 ¯ spectral region between 948 and 970 cm-1 (zoomed 458 
in phosphate region is shown in Figure S3). While these peaks are not very 459 
pronounced their signal-to-noise ratio was >3 and therefore deconvolution was 460 
possible, as others have also previously shown [57]. Principal component 461 
analysis (PCA) on the phosphate spectral region was also carried out (Figure 462 
S3B). It establishes that while there is overlap between different time-points 463 
signifying similarity in spectral features there is some segregation (in PC1, PC3 464 
and PC4) as well indicating differences between them despite lesser variables 465 
(due to the reduced spectral region analysed) in the PCA. Since the differences 466 
seem prominent enough in the class means we analysed the differences 467 
through deconvolution as described below. 468 
 469 
In osteogenic COBs cultures, deconvolution of peak heights of combined 470 
phosphates between 948 cm-1 and 970 cm-1 show a decrease in phosphate 471 
peak height after day 3 (SI Figure S2A). In non- osteogenic COBs cultures, 472 
deconvolution of peak heights of combined phosphates show no change 473 
between day 3 and day 5. There is a decrease in peak height at day 7, followed 474 
by an increase at day 14 (SI figure S2B). More detailed analysis of osteogenic 475 
cultures of COBs, revealed that ACP is present with CAP at day 3 compared to 476 
other days while OCP is absent. Octacalcium phosphate (OCP) is a well-477 
documented transient precursor to hydroxyapatite [42, 48, 49, 55]. OCP was 478 
detected only after 5 days of osteogenic COBs culture, together with a reduction 479 
in ACP and CAP (Figure 6A-C).  480 
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 481 
At day 7 of culture there is a significant decrease in ACP, a slight drop in CAP 482 
and increased OCP. After 14 days there is a dramatic increase in the presence 483 
of all phosphate species. This increase corresponds with a significant increase 484 
in ALP activity (Figure 2A), as well as increased collagen deposition (Figure  485 
2B). Primary cells are heterogeneous in nature, they are known to contain cell 486 
populations at varying degrees of differentiation and maturity [58, 59]. This 487 
heterogeneity is evident in Raman spectra obtained from early time points (from 488 
day 3 to 5) which show a greater variability owing to differing levels of cell 489 
maturity.  This could explain the presence of multiple phosphate species in 490 
COBs cultures. COBs are at different stages of differentiation and maturation 491 
and therefore differing phosphate species are present simultaneously. It has 492 
been suggested that the presence of pre-cursor phosphate species aids in the 493 
formation of hydroxyapatite, which could be considered the terminal product of 494 
mineral formation and the most stable calcium phosphate salt [60]. Early work 495 
by Brown et al reported on the existence of octacalcium phosphate (OCP) as a 496 
possible intermediate for hydroxyapatite and later went on to characterise the 497 
Figure 6. Modifications in phosphate species are evident from 5 days of calvarial osteoblast culture. 
Deconvolution analysis of phosphate species detected by Raman spectroscopy in COBs reveals alterations in 
amorphous calcium phosphate (A; ACP), carbonated apatite (B; CAP) and octacalcium phosphate (C; OCP). Data 
presented as mean of deconvolution ± SEM (p< 0.05 *** p<0.0001 ****). (D) Schematic representation of 
fluctuating concentrations of intermediate calcium phosphate species. 
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Raman band assignment  for OCP [56, 61]. Sometimes referred to as β- TCP, 498 
OCP is thought to have band positions located at 955 cm-1 and 970 cm-1. In 499 
their study of calvarial cultures, Crane et al, report on the presence of an OCP 500 
like mineral at 955 cm-1, but this mineral is not present in our COBs cultures 501 
[42]. An important pitfall was highlighted in a study by Stewart et al, where they 502 
describe the presence of β-TCP (975 cm-1) in their MC3T3-E1 cell cultures as 503 
a consequence of the use of excess β- glycerophosphate [48]. It should be 504 
noted that the use of excess β- glycerophosphate (>5 mM) in osteoblast culture 505 
can lead to dystrophic mineralisation and impaired cell viability, this could also 506 
account for the presence of unexpected phosphate species [23, 62].  507 
 508 
 509 
Multivariate  analysis of COBs’ spectra 510 
 511 
Multivariate analysis was conducted by means of a pairwise comparison 512 
between each time point. Figure 7 represents the 3D scatterplots from the 513 
pairwise comparisons. Figure 7A shows the 3D plot of results attained from the 514 
PCA of Raman spectra collected from COBs cultured for 5 and 3 days. PC1, 515 
PC2 and PC3 represent 64.7%, 24.4% and 3.52% of the variance between the 516 
dataset respectively. With exception of one outlier, there is a distinct separation 517 
between day 5 and day 3. The PC1 loading (SI figure 4Ai) indicates that the 518 
entire spectrum contributes to the group separation between these time points. 519 
From the PC2 loading (SI figure 4Aii) Amide I, CH2 wag and the 782 cm-1 peak 520 
appear to contribute most to the variance.  521 
The 3D scatterplot for results obtained from the PCA of Raman spectra 522 
collected from day 7 and day 5 of culture, shows that although the time points 523 
remain clearly separated, the loadings are weighted differently this time. PC1 524 
accounts for 71.3% of the variance, PC2 for 21.3% and PC3 for just 1.89% of 525 
the variance. The PC1 loadings (SI figure 4B i) are very similar to the PC1 526 
loadings from day 5 and day 3, however, peaks in the phosphate symmetric 527 
stretch region (~950 cm-1), though a small percentage, also contribute to the 528 
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variance in PC1. In PC2 the contribution of peaks in the phosphate symmetric 529 
stretch region contribute to a larger percentage of the overall variance.  530 
 531 
The PCA analysis of Raman spectra collected from day 7 and day 14, as 532 
revealed by the 3D scatterplot shows the least amount of separation between 533 
the groups (Figure 7C). PC1 accounted for 50.5% of variance, PC2 43% and 534 
PC3 1.96%. The components of PC1 are distinguishable as groups, but the 535 
components of PC2 are less obvious. It is noteworthy that the results from the 536 
ALP assay showed significant increases between cells cultured for 7 and 14 537 
days in osteogenic media. The deconvolution analysis of the nucleic acid peak 538 
and the 1450 cm-1 collagen matrix peak also revealed significant differences 539 
between day 7 and 14. The PC1 loading (SI Figure 4Ci) of the PCA output of 540 
Figure 7. 3D scatterplots of pairwise PCA analysis output. (A) PCA analysis of day 5 and day 3 spectra of 
COBs.  PC1, PC2 and PC3 represent 64.7%, 24.4% and 3.52% of the variance between the data set respectively. 
(B) PCA analysis of day 7 and day 5 spectra of COBs. PC1, PC2 and PC3 represent 71.3%, 21.3% and 1.89% of 
the variance between the data set respectively. (C) PCA analysis of day 14 and day 7 COBs. PC1, PC2 and PC3 
represent 50.5%, 43% and 1.96% of the variance between the data set respectively.  
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the pairwise comparison between day 7 and 14 indicates that Amide I, CH2 wag 541 
and  Amide III contribute to the overall variance. The broad Amide III shoulder 542 
is dominated by matrix components. The Amide III shoulder visible in the class 543 
mean spectrum of COBs cultured for 14 days in osteogenic media (Figure 1C), 544 
appears to be more pronounced at day 14 when compared with day 7, 545 
suggesting changes in protein structure over time.   546 
 547 
In general the PCA analysis has confirmed that there are significant differences 548 
between COBs cultured over time. Changes in matrix composition and structure 549 
contribute to these differences. Changes in the phosphate symmetric stretch 550 
were also detected, and appear to contribute to variance, though to a much 551 
lesser degree. In most cases the PC loadings indicate a lot of variation over the 552 
entire spectrum, and as such the subtle differences are lost. Deconvolution of 553 
individual peaks remains most appropriate to detect these subtle changes. The 554 
presence of OCP in Raman spectra, could be used as an early marker of 555 
osteogenic commitment, detectable before the onset of mineralisation and the 556 
appearance of HA. The ability of Raman spectroscopy to detect the presence 557 
of OCP before changes are apparent in ALP assay highlights the suitability of 558 
this technique to be used as a tool for characterising early cell behaviour.  559 
 560 
4 Conclusion 561 
 562 
Our results highlight the ability of Raman spectroscopy to detect subtle changes 563 
in osteoblast behaviour in primary cultures shortly after extraction from mice. 564 
Where the ALP assay was able to provide some information regarding changes 565 
in COBs’ activity, by employing Raman spectroscopy, we could characterise a 566 
signature of early osteoblast behaviour by quantifying changes in DNA, 567 
phosphate species and collagen matrix during different stages of osteogenic 568 
commitment. Raman spectroscopy could indicate early changes and provide 569 
enhanced information regarding the phenotype of specific osteoblast 570 
populations which was not possible using conventional approaches. Whilst 571 
Raman spectroscopy could provide a means to assess the direct effects of 572 
growing cells on artificial implant substrates, we are not suggesting that the 573 
results of this study on quartz are applicable to all implant surfaces. This would, 574 
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however, only be possible if the Raman signals from the implant coatings could 575 
be differentiated from the signals generated by the cells or from boney 576 
outgrowths prior to osseointegration.  Most importantly, if this caveat is taken 577 
into account, Raman spectroscopy has shown potential to be used to 578 
investigate early markers of differentiation in cells growing on implant coatings. 579 
It could be used as a predictor of potential bone outgrowth and osseointegration 580 
of these implants in vivo, which could lead to improved outcome of artificial 581 
implants.  582 
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